Literature DB >> 11799329

Diagnostic potential of targeted electrical impedance scanning in classifying suspicious breast lesions.

Annika Wersebe1, Katja Siegmann, Ute Krainick, Nikos Fersis, Ulrich Vogel, Claus D Claussen, Markus Müller-Schimpfle.   

Abstract

RATIONALE AND
OBJECTIVE: To evaluate the potential of targeted electrical impedance scanning (EIS) for classifying suspicious breast lesions.
METHODS: EIS was performed in full knowledge of mammographic findings and findings of clinical breast examination. One hundred seventeen patients with a total of 129 breast lesions were examined with EIS before breast biopsy (surgical excision or vacuum core biopsy). Diagnostic indexes of targeted EIS were calculated depending on major lesion characteristics. Capacitance and conductivity of all positive spots (S) and the surrounding normal breast tissue (NBT) were quantified using ROI measurements. The ratio S/NBT was calculated to compare true positive (n = 44) and false positive (n = 18) spots.
RESULTS: With respect to histology, of the 129 lesions 71 were malignant and 58 lesions were benign. Overall sensitivity of targeted EIS was 62%, specificity 69%, PPV 71%, and NPV 60%. Sensitivity of EIS varied depending on the tumor size, which was between 48% (> 20 mm) and 71% (11-20 mm). Highest specificity (86%) was observed for large lesions (> 20 mm); however, the NPV was only 35% for lesions of that size. NPV was higher for nonpalpable lesions (74%) and clusters of microcalcifications (85.7%) compared with palpable lesions (39%) and solid lesions (44%). There was no statistical difference of S/NBT ratio neither for conductivity nor capacitance of true and false positive spots. Compared with true positive spots a trend of a higher conductivity ratio at 100 Hz and 200 Hz was seen for false positive spots.
CONCLUSION: EIS showed mediocre overall diagnostic accuracy for classifying suspicious breast lesions. Quantitative analysis of positive EIS findings did not help to differentiate between false and true positive spots.

Entities:  

Mesh:

Year:  2002        PMID: 11799329     DOI: 10.1097/00004424-200202000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  7 in total

1.  Electrical impedance scanning-application of this new technique for lymph node evaluation in children.

Authors:  Hans-Joachim Mentzel; Ansgar Malich; Karim Kentouche; Martin Freesmeyer; Joachim Böttcher; Gerlind Schneider; Bernd Gruhn; Susanna Vogt; Felix Zintl; Roselle Anderson; Werner A Kaiser
Journal:  Pediatr Radiol       Date:  2003-05-01

2.  Influence of size and depth on accuracy of electrical impedance scanning.

Authors:  Ansgar Malich; Mirjam Facius; Roselle Anderson; Joachim Böttcher; Dieter Sauner; Andreas Hansch; Christiane Marx; Alexander Petrovitch; Stefan Pfleiderer; Werner Kaiser
Journal:  Eur Radiol       Date:  2003-07-05       Impact factor: 5.315

Review 3.  The Accuracy of Electrical Impedance Tomography for Breast Cancer Detection: A Systematic Review and Meta-Analysis.

Authors:  Zahra Rezanejad Gatabi; Mehri Mirhoseini; Nasrin Khajeali; Iman Rezanezhad Gatabi; Maedeh Dabbaghianamiri; Sara Dorri
Journal:  Breast J       Date:  2022-05-26       Impact factor: 2.269

4.  The impact of lesion vascularisation on tumours detection by electrical impedance scanning at 200 Hz.

Authors:  A Malich; B Scholz; A Kott; M Facius; Dr Fischer; Mg Freesmeyer
Journal:  Biomed Imaging Interv J       Date:  2007-10-01

Review 5.  Technology review: the use of electrical impedance scanning in the detection of breast cancer.

Authors:  Tyna A Hope; Siân E Iles
Journal:  Breast Cancer Res       Date:  2003-11-13       Impact factor: 6.466

6.  Modern breast cancer detection: a technological review.

Authors:  Adam B Nover; Shami Jagtap; Waqas Anjum; Hakki Yegingil; Wan Y Shih; Wei-Heng Shih; Ari D Brooks
Journal:  Int J Biomed Imaging       Date:  2009-12-28

7.  Breast imaging in the new era.

Authors:  K Planche; S Vinnicombe
Journal:  Cancer Imaging       Date:  2004-01-12       Impact factor: 3.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.